Nephrologist @RMANewMexico. GN aficionado. Principal Investigator. Clinical Trialist
Albuquerque, NM
Joined February 2017
- Tweets2.2K
- Following567
- Followers1.5K
- Likes5.6K
With Dr. Bruce Julian, a legend in the field of IgA Nephropathy. So glad to have been mentored by him and @DanaRizk1 at @UAB_NRTC.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Recording starting soon! Will discuss the latest in the field of MN from ASN Kidney week.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Excited to be part of the BRIDGE-IgAN Registry and contribute to this multicenter collaboration advancing real-world research in IgA nephropathy! 🫘🔬
Thank you @GeorgeVasquezR2 for the collaboration and for including me in this exciting initiative. It is great to see investigators across institutions coming together to better understand IgAN and ultimately improve patient care.
Proud to see our collaborative work at ASN Kidney Week 2026! 🤝
@Nephronpower @ASNKidney
#IgAN #KidneyWk #Nephrology #GlomerularDisease #ClinicalResearch #Collaboration
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Centers of Excellence: Two new publications. One shared vision. GlomCon × ISGD!
Two consensus papers in Kidney International and Kidney International Reports mark an important step toward unifying glomerular disease care, research, education, and global access.
A unified global certification program is in development. More soon!
Read the papers here:
sciencedirect.com/science/ar…
sciencedirect.com/science/ar…
Our comprehensive, thorough, and up-to-date review on B-Cell modulation in Immunoglobulin A Nephropathy is out. @DanaRizk1 @UAB_NRTC @RMANewMexico
frontiersin.org/journals/imm…
We discuss the preclinical, translational, and clinical utilization of drugs affecting the B-Cell pathway in IgAN, including targeting the mucosal immunity, BAFF-APRIL axis, plasma-cell and CD-38 targeting, and other B-Cell signaling pathways.
We also focus on the latest and detailed therapeutic treatment landscape in this disease space. Great collaboration with Jan Novak, PhD and @DanaRizk1 .
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Professor Roccatello giving a State of the Art lecture on Cryoglobulins.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Dr. Glassock presenting on treatment of primary podocytopaties at the Mayo GNs Course.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Targeting B cells in immune-mediated kidney diseases: conclusions from @goKDIGO Controversies Conference ca. 2026
#Nephpearls #RKDSummit
👉🏼 pubmed.ncbi.nlm.nih.gov/4203…
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
This year's #PKD session at #GlomConHawaii was a success; so much energy in the room, so many people wanting to get involved.
Quick heads up: PKD-MDP applications close tomorrow. @GlomCon @fouadchebib @pranavgarimella @ndahl48
glomcon.org/pkdmd-program
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Current advances in the field and their effects on diagnostic and therapeutic algorithms open the path towards personalized use of traditional treatments and newly available drugs, which should improve outcomes and quality of life for patients with #podocytopathies (from lecture of @Tobias_B_Huber)
#Nephpearls #RKDSummit
👉🏼 pubmed.ncbi.nlm.nih.gov/4138…
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Tough case.
LM: granulomatous interstitial nephritis, extensive.
IF: negative.
Look carefully and you start seeing small foci of necrosis in glomeruli, surrounded by inflammation/rupture of Bowman’s capsule.
Dx: 1. Granulomatous interstitial nephritis. 2. Necrotizing glomerulonephritis, pauci-immune. (both possibly drug related).
30-yr woman with rash, serum creatinine 10, bipolar disorder-just started treatment. ANCA, other serology negative.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
I could add 10 more to the list Besides being the most common GN in the world, IgAN is the most heterogeneous glomerulopathy both histopathologically and clinically.
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Starts in 90 minutes (1 PM CST). Join us and vote on your thoughts about the diagnosis and treatment! @TWhittier_RUSH will offer some teaching on the case.
We are finally back! Please join us TOMORROW 9/17/26 at 1 PM CST for a LIVE @Rush_Nephrology renal biopsy conference. This is a disease for which there is no standard of care. That's my story and I'm sticking to it! #RushRenalRules
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Severe IgA nephropathy and drug’s effect? Here you go! Thank you as always ✨ @NephRodby @TWhittier_RUSH @Proximal_Baxi @BajinderR @Rush_Nephrology @Nephronpower
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Humbled and truly honored to serve as a Visiting Faculty Member with the Division of Nephrology and Hypertension at @MayoClinic (Rochester, MN)
I had the opportunity to discuss two passions of mine today:
Grand Rounds: "An evidence-based review of acute inpatient hypertension management"
Renal Research Forum: "Leveraging technology & #SoMe as a powerful tool for #Nephrology education"
🙏 Thank you to the @MayoClinicNeph team for the wonderful hospitality!
#MedEd #Nephpearls – at Byron, MN
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
If you understand the immune process in LN you don’t need a biopsy. If you don’t, a biopsy will not help. 😜
Protocol kidney biopsy in the management of proliferative (class III/IV) lupus nephritis: barking up the wrong tree! academic.oup.com/ndt/article…
Arun Rajasekaran, MD, FACP, FASN, FNKF retweeted
Membranous nephropathy in the allograft kidney.
Contactin 1 (CNTN1) was detected using mass spectrometry.
Evaluation revealed long history of chronic demyelinating polyneuropathy.
De Novo Contactin-1- associated Membranous Nephropathy in Kidney Allograft. - Kidney International Reports kireports.org/article/S2468-…
Teaching points-
1. CNTN1-associated MN is rare type of MN associated with chronic inflammatory demyelinating polyneuropathy.
2. CNTN1-associated MN can occur in the allograft many years after the transplant.
3. Clinical and laboratory evaluation in such cases will reveal a chronic inflammatory demyelinating polyneuropathy, although the disease may be clinically quiescent.
4. Laser microdissection and mass spectrometry is a useful methodology for detection of MN antigens.
